KEAP1 and schizophrenia: Patients with schizophrenia exhibited underexpression of KEAP1, a key regulator of ferroptosis, along with elevated intracellular Fe2+ levels and increased MDA concentrations, indicating enhanced lipid peroxidation and oxidative stress.